Elicio Therapeutics Announces Virtual Presentation of Data on its Amphiphile-CpG Adjuvant at the Vaccines Summit 2021

NEXT STORY
Century Therapeutics Announces Its Addition to the Russell 2000® Index
PREV STORY
Elucida Oncology Announces First Patient Dosed in Phase 1/2 Study of ELU001 in Patients with Advanced, Recurrent, or Refractory Cancers Overexpressing Folate-Receptor Alpha (FRα)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiesi Group Announces Establishment of New Global Rare Diseases Division

author_avatar
NASDAQ Market News

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today ...

author_avatar
NASDAQ Market News

BeyondSpring Announces Submission of New Drug Application to U.S. FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)

author_avatar
NASDAQ Market News